CompletedPhase 2NCT03601806

Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

Studying Kaposi sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AIDS Malignancy Consortium
Principal Investigator
Susan E. Krown, MD
AIDS Malignancy Consortium
Intervention
Laboratory Biomarker Analysis(other)
Enrollment
26 target
Eligibility
18 years · All sexes
Timeline
2021 – 2025

Study locations (3)

Collaborators

National Cancer Institute (NCI) · The Emmes Company, LLC · University of Arkansas · Montefiore Medical Center · University of Stellenbosch · Weill Medical College of Cornell University · University of California, Los Angeles

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03601806 on ClinicalTrials.gov

Other trials for Kaposi sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Kaposi sarcoma →

← Back to all trials